Literature DB >> 33532015

Herlyn-Werner-Wunderlich syndrome with borderline serous cystadenoma of the ovary: case report and literature review.

Johara AlMulhim1, Mohannad Rasheed AlRasheed2.   

Abstract

Herlyn-Werner-Wunderlich syndrome, is a rare urogenital congenital anomaly. Coexisting Mullerian ducts anomalies and ovarian neoplasms are rarely reported. We present the first case of Herlyn-Werner-Wunderlich syndrome with borderline serous neoplasm of the ovary. A 29-year-old married female with primary infertility and elevated level of cancer antigen 125 (CA-125), underwent pelvic magnetic resonance imaging for evaluation which revealed uterus didelphys, obstructed right hemivagina, right renal agenesis as well as right ovarian cystic lesion. Ovary preserving laparoscopic cystectomy was performed with a pathological diagnosis of a serous borderline tumor. Although rarely reported, Mullerian ducts anomalies and uterine or ovarian remnant neoplasms can occur. These few case reports may suggest an underlying, yet to be discovered, genetic association of Mullerian ducts anomalies and development of ovarian neoplasms of various pathological subtypes.
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Congenital anomalies; Kidneys; Ovarian neoplasms

Year:  2021        PMID: 33532015      PMCID: PMC7835497          DOI: 10.1016/j.radcr.2020.09.048

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Herlyn-Werner-Wunderlich syndrome (HWWS), is a rare congenital anomaly of the female urogenital tract caused by abnormalities in the development of the Mullerian and Wolffian ducts resulting in uterus didelphys, obstructed hemivagina, and associated ipsilateral renal anomaly [1]. Renal anomalies range from ectopic ureteric insertion and renal dysplasia to complete ipsilateral renal agenesis [2,3]. This syndrome is regarded as Class III Mullerian dysgenesis and constitutes around 5%-10% of the reported Mullerian duct dysgenesis cases. Patients with this syndrome are usually diagnosed around or after puberty and present with dysmenorrhea, urine retention, endometriosis, or complicated delivery [2,4]. Patients with Mullerian dysgenesis syndrome have normal ovarian development. Few cases have been reported in the current literature about the development of uterine or ovarian tumors in patients with different classes of Mullerian dysgenesis but up to the authors’ best knowledge, there are no previous reports of ovarian tumor development in HWWS [5], [6], [7]. Thus, we report the first case of ovarian tumor development in HWWS.

Case report

We report a case of 29-year-old married female that was being evaluated in a private hospital for primary infertility where a routine gynecological ultrasound was preformed which reported a right ovarian complex lesion and uterus didelphys. She was referred to our hospital for a full evaluation. Upon evaluation, the patient was asymptomatic with regular normal flow menses. Her general physical exam was unremarkable. Speculum examination showed a normal single vagina and single cervix. No abnormal discharge. A repeat gynecological ultrasound was performed by the treating gynecologist and reported a right ovarian complex lesion and uterus didelphys; hence a pelvic magnetic resonance imaging was ordered for evaluation. CA-125 level was elevated at 384 U/mL (Normal range: 0-35). Pelvic magnetic resonance imaging revealed 2 normal uterine horns, 2 cervices, and 2 vaginas, in keeping with uterus didelphys, and an absent right kidney (Fig. 1). The right hemivagina was distended suggestive of obstructing vaginal septum and filled with T1 and T2 intermediate fluid as well as dependent high T1 and low T2 contents implicative of a repetitive hemorrhagic process (Fig. 2). There was also a large right ovarian cystic lesion showing intermediate T1 and T2 internal signals with enhancing papillary soft tissue components (Fig. 3). There was no evidence of peritoneal disease, lymph nodal involvement, or distant metastasis. The left ovary and left kidney were normal. Therefore, a diagnosis of HWWS with right ovarian neoplasm was made. The patient underwent a laparoscopic organ-preserving right ovarian cystectomy and the pathology report was of a serous borderline tumor (Fig. 4). The patient therefore did not require postoperative chemotherapy and was advised for annual clinical, radiological, and CA-125 level follow-up.
Fig. 1

Coronal high resolution T2 of the pelvis and coronal HASTE of the abdomen demonstrate 2 separate uterine cavities, right ovarian cystic lesion and congenitally absent right kidney.

Fig. 2

Axial T2 and axial nonenhanced T1 fat sat demonstrating 2 separate cervices and vaginas. The right hemivagina is obstructed with internal blood products.

Fig. 3

Axial T2 at the level of the ovaries showing large right cystic lesion with internal frond like projections.

Fig. 4

Postresection histopathology specimen of the resected serous borderline tumor: Left image (Hematoxylin and eosin stain, × 4), right image (Hematoxylin and eosin stain, × 20).

Coronal high resolution T2 of the pelvis and coronal HASTE of the abdomen demonstrate 2 separate uterine cavities, right ovarian cystic lesion and congenitally absent right kidney. Axial T2 and axial nonenhanced T1 fat sat demonstrating 2 separate cervices and vaginas. The right hemivagina is obstructed with internal blood products. Axial T2 at the level of the ovaries showing large right cystic lesion with internal frond like projections. Postresection histopathology specimen of the resected serous borderline tumor: Left image (Hematoxylin and eosin stain, × 4), right image (Hematoxylin and eosin stain, × 20). Concerning the uterine anomaly, the patient was not a candidate for a unification surgery. She underwent a laparoscopic right hemivaginal drainage for hematocolpos and vaginal septotomy. Fertility issues were discussed with the patient and she was a candidate for future in vitro fertilization.

Discussion

Mullerian duct anomalies are rare with varying reported worldwide prevalence ranging between 1% and 5.5% [8]. There are 7 classes of Mullerian duct anomalies according to the American Society of Reproductive Medicine classification with HWWS regarded as Class III Mullerian dysgenesis [9]. HWWS, is a rare congenital anomaly of the female urogenital tract caused by abnormalities in the development of the Mullerian and Wolffian ducts [1,2]. It has been frequently recognized as Mullerian dysgenesis over the past few decades, but this theory fails to explain the complexity of the vaginal abnormalities in this syndrome. To understand the complexity of this syndrome, it's important to review the current postulated theory on its embryogenesis. The mesonephric ducts on each side out-pouch to form the mesonephric diverticulum by the fifth week of gestation [10]. Soon after, the diverticulum will become the ureteric bud that triggers the kidney formation by the mesonephric blastema. The paramesonephric ducts will begin to develop by the seventh week of gestation lateral to the mesonephric ducts then migrate medially to it. It has been stated that the development of the paramesonephric ducts as well as their positioning and fusion depends largely on the factors released by the mesonephric ducts [11]. Subsequent fusion of the mesonephric ducts occurs and resorption of the midline septum results in normal uterine formation. The Acines hypothesis postulates that the vagina is derived from the Wolffian ducts instead of the classical theory of the upper two-thirds derived from the Mullerian ducts and lower third from the sinovaginal bulb, however, the vaginal lining epithelium is derived from the Mullerian ducts [11,12]. Hence, any developmental abnormality of the Mullerian ducts will affect the ipsilateral hemivagina, ureteric bud, and uterine fusion. Patients with HWWS usually present around puberty with symptoms related to mass effect due to enlarging obstructed hemivagina, for example; vague cyclical lower abdominal pain, urine retention, lower abdominal mass, and pelvic inflammatory disease [2,4]. A retrospective cohort analysis reported 43 prepubertal patients with HWWS, most of which were diagnosed at birth or soon afterward by investigating concomitant renal anomalies [3]. Patients who were asymptomatic in the peripubertal period would present later in life with problems related to endometriosis or infertility [13]. Historically, The main treatment of those patients is usually symptomatic and was delivered in forms of vaginal drainage, vaginal septotomy with or without marsupialization [14]. A retrospective analysis of 14 patients with HWWS performed by Troncon et al (2018) [15], reported that most of the patients presented by after menarche with dysmenorrhea and are usually offered symptomatic treatment with removal of the obstructing vaginal septum. Also, 11 of 14 patients did not report natural successful pregnancy during 10 years of follow up. Few case reports exist of successful pregnancy outcomes in patients with uterus didelphys after intrauterine insemination or in vitro fertilization [16]. The development of uterine remnants neoplasms such as leiomyomas or adenomyosis has been reported in patients with Mullerian ducts anomalies [17]. Ovarian remnants neoplasms are rarely reported in these patients as they have normal ovarian development and function. A literature review by Miao et al (2018) [5], collected few case reports of Mullerian ducts anomalies with various types of ovarian neoplasms, the majority of which were found to be benign after histopathological evaluation. Huepenbecker et al (2017) [6], reported a rare occurrence of ovarian cystadenocarcinoma in two sisters affected by MRKH syndrome with normal 46XY karyotype and negative ovarian cancer genetic panel screening. Also, Villa et al (2019) [7], described a case of a 33-year-old patient with MRKH syndrome, ovarian low-grade serous carcinoma, and normal karyotype as well as negative screening for the breast cancer gene 1 and 2 (BRCA1/BRCA2). Up to our best knowledge, no case report of HWWS with ovarian neoplasm exists to date. The authors are aware of the great possibility that the co-occurrence of those 2 entities is incidental as our patient had no family history of ovarian, uterine, or breast cancers with negative BRCA1/BRCA2 screening and a normal karyotype. However, the aforementioned few case reports may open an underlying genetic research window for such patients with complex multiorgan involvement.

Patient Consent Statement

Written informed consent from the patient is not required by the IRB of our institute for radiology case reports publications as there is no exposure of patient's identifying information.
  1 in total

1.  Herlyn-Werner-Wunderlich syndrome (HWWS)-associated gynecological malignancies: A case report and literature review.

Authors:  Seiji Mabuchi; Harue Hayashida; Chiaki Kubo; Masahiko Takemura; Shoji Kamiura
Journal:  Gynecol Oncol Rep       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.